Samarakoon Asanga, Chu Haiyan, Malarkannan Subramaniam
Laboratory of Molecular Immunology, Blood Research Institute, Division of Neoplastic Diseases, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, United States.
Mol Immunol. 2009 Mar;46(6):1011-9. doi: 10.1016/j.molimm.2008.09.035. Epub 2008 Dec 10.
Unlike T and B cells, NK cells lack variable, clonotypic receptors that recognize foreign antigens. Instead, NK cells depend on conserved receptors such as NKG2D. NKG2D recognizes a variety of inducible self-proteins that belong to the non-classical MHC class I family. They include ULBP (1-3), MIC (A & B) in human and H60 (a, b & c), Rae-1 (alpha-epsilon) and Mult1 in mice. These self-proteins are expressed due to pathological stimuli, share limited amino acid homology and form the molecular basis for NKG2D-mediated activation. Recent studies have vastly improved our understanding of NKG2D receptor-mediated activation, signaling and function. However, a detailed knowledge on the immunobiology of its ligands is lacking. How many is too many? Is NKG2D the only receptor for these ligands? Where are these ligands expressed? What are the molecular mechanisms that regulate their expression? Do normal cells express these ligands? Does the communication between NKG2D receptor and its ligands travel through a two way road? If so, what do the 'target' cells get in turn, only death? How efficient are these ligands as molecular targets for NK cell-mediated tumor immunotherapy?
与T细胞和B细胞不同,自然杀伤(NK)细胞缺乏识别外来抗原的可变克隆型受体。相反,NK细胞依赖于保守受体,如NKG2D。NKG2D识别多种属于非经典MHC I类家族的可诱导自身蛋白。它们包括人类的ULBP(1 - 3)、MIC(A和B)以及小鼠的H60(a、b和c)、Rae - 1(α - ε)和Mult1。这些自身蛋白因病理刺激而表达,氨基酸同源性有限,构成了NKG2D介导的激活的分子基础。最近的研究极大地增进了我们对NKG2D受体介导的激活、信号传导和功能的理解。然而,关于其配体的免疫生物学的详细知识仍然缺乏。多少才算过多?NKG2D是这些配体的唯一受体吗?这些配体在哪里表达?调节它们表达的分子机制是什么?正常细胞会表达这些配体吗?NKG2D受体与其配体之间的通讯是双向的吗?如果是,“靶”细胞反过来会得到什么,只有死亡吗?这些配体作为NK细胞介导的肿瘤免疫治疗的分子靶点效率如何?